Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 181 - 190 of 202 for excel. (0.17 seconds)

Shanghai Fosun Pharma has long followed an audacious...
Colorcon, a privately held US CRO/CMO excipient maker...
Benitec Biopharma of Australia announced it will pay $4.5...
A giant gastric cancer screening study, which will test...
WuXi PharmaTech, China's largest CRO/CMO, formally...
Roche will acquire GeneWEAVE BioSciences, a US...
Anpac Bio-Medical Science Co. of Shanghai announced that...
Ascletis Pharma, a Hangzhou clinical-stage novel biotech,...
Jiangsu Hengrui Medicine out-licensed global rights...
RuiYi, Inc., a San Diego-Shanghai biotech, has begun a...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here